KLOW
Kisspeptin / CJC-1295 / Ipamorelin / Tesamorelin / GHK-Cu / BPC-157
KLOW is a multi-peptide blend popularised by anti-aging clinics. The composition varies by source — common members include Kisspeptin-10 (HPG-axis stimulation), CJC-1295 (GHRH analogue), Ipamorelin (GH secretagogue), and Tesamorelin (GHRH analogue). Some formulations also include GHK-Cu and BPC-157.
Compute a dose for any component
Switch between stack members using the chip strip. Each is preset to a typical vial and dose.
Why these peptides together
KLOW combines HPG-axis stimulation (kisspeptin), GH-axis amplification (CJC-1295 + ipamorelin + tesamorelin), and ancillary recovery support (BPC-157, GHK-Cu in some versions). It targets endogenous endocrine activity rather than supplementing exogenous hormone directly.
How it's typically run
Compounding pharmacies typically supply KLOW as a single multi-peptide vial reconstituted with BAC water. Dose ranges and component ratios vary by compounder — always follow the specific label on your vial. A typical protocol is one subcutaneous injection nightly, five nights per week.
Frequently asked questions
- Are KLOW components reconstituted together?
- Yes — KLOW is usually supplied as a single multi-peptide lyophilized vial that is reconstituted with one volume of BAC water. The calculator can compute the per-component concentration once the total mass is known.
- What's the difference between KLOW and GLOW?
- Both are multi-peptide cocktails, but with different members and goals. GLOW typically combines GHK-Cu + BPC-157 + TB-500 (recovery / skin / connective-tissue focus). KLOW skews toward GH-axis stimulation.
PeptideDose is an educational reference. It is not medical advice and does not replace consultation with a licensed healthcare provider. Doses shown in presets are derived from published protocols and product labels — they are not personal recommendations.